A cyclopropane derivative and its photocatalytic synthesis method
A photocatalytic synthesis method was developed to react N-methyl-p-toluenesulfonamides and alkenyl diazo compounds in the presence of a base to generate cyclopropane derivatives. This method solves the problems of numerous steps, harsh conditions, and low yield in traditional synthesis methods, and achieves a highly efficient and simple cyclization addition reaction, which is applicable to alkaloids and drug molecules.
Patent Information
- Application Number
- CN202611337596.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-31
- Publication Date
- 2026-11-17
AI Technical Summary
Traditional methods for synthesizing cyclopropane derivatives suffer from numerous reaction steps, harsh reaction conditions, low yields, and poor tolerance of functional groups.
A photocatalytic synthesis method was adopted to react N-methyl-p-toluenesulfonamides and alkenyl diazo compounds in the presence of a base to generate cyclopropane derivatives. The sulfonamide compounds were then used as nitrogen radical precursors to undergo cyclization addition reactions with the alkenyl diazo compounds under photocatalytic conditions.
This method enables the efficient synthesis of cyclopropane derivatives at room temperature with a yield of 84%, high atom utilization, simplified synthesis steps, and conforms to the development concept of green chemistry. It is suitable for applications in alkaloids and drug molecules.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] This invention belongs to the field of organic synthesis technology, specifically relating to a cyclopropane derivative and its photocatalytic synthesis method. Background Technology
[0002] Cyclopropane derivatives are widely found in various alkaloids, drug molecules, and natural products, exhibiting significant biological activity. Due to their unique ring strain and high reactivity, cyclopropanes have important applications in organic synthesis and medicinal chemistry, and potential applications in natural product synthesis, drug molecule design, and functional materials development. Traditional cyclopropane synthesis often follows the synthetic route proposed by Perkin W. H et al., using diethyl malonate and 1,2-dibromoethane as starting materials, and achieving dialkylation under sodium ethoxide catalysis [(a) Perkin, W. H, et al. Ber.Dtsch. Chem. Ges. 1884, 17: 54-59. (b) Perkin, W. H, et al. Ber. Dtsch. Chem. Ges. 1884, 17: 1522-1527. (c) Perkin, W. H, et al. Ber. Dtsch. Chem. Ges.1884, 17: 1652-1658. (d) Perkin, W. H, et al. Ber. Dtsch. Chem. Ges. 1885,18: 682-684. (e) Kulinkovich, O. G, et al. Synthesis, 1991, 1991: 2244-2245. (f) Panish, R, et al. J. Am. Chem. Soc. 2013, 135: 9283 [9286.]. The reaction process is plagued by many problems, such as harsh reaction conditions like high temperature and high pressure, cumbersome and time-consuming synthesis process, low yield, and poor tolerance of functional groups.
[0003] With the rapid development of photocatalysis, chemists have discovered that alkenyl diazo compounds, as free radical acceptors, exhibit good selectivity in photocatalytic reactions; simultaneously, sulfonamide compounds form sulfonamide nitrogen radicals under photocatalytic conditions, which can undergo cyclization addition with unsaturated bonds. Existing literature often reports the reaction processes of diazo compounds with double and triple bonds, but reports on the synthesis of cyclopropane derivatives from sulfonamides and alkenyl diazo compounds are extremely rare [(g) MaJ J. et al.]. Science, 2021, 371(6536): 1338-1345. (h) Guo Y, Empel C, Pei C. et al. Organic Letters , 2020, 22(13): 5126-5130. (i) Xiao T, Mei M, He Y. et al. Chemical Communications , 2018, 54(64): 8865-8868. (j) Jana S, Yang Z. M,Koenigs, et al. Angewandte Chemie International Edition , 2020, 59(14): 5562-5566. (k) Zhang R, Zhang ZK, Wang K. The Journal of Organic Chemistry , 2020,85 (15): 9791-9800. (l) Francisco J, Sarabia, Eric M. et al. Organic Letters ,2017, 19(11): 2865-2868.].
[0004] Traditional methods for synthesizing cyclopropane derivatives suffer from numerous reaction steps, require high-temperature and high-pressure reaction conditions, have low yields, and exhibit poor functional group tolerance. Therefore, a novel synthetic method for cyclopropane derivatives is needed to simplify the process, optimize synthesis conditions, and improve yields. This will allow for a more efficient and concise approach to synthesizing cyclopropane derivatives. Summary of the Invention
[0005] In order to overcome the shortcomings of the prior art, the present invention aims to provide a cyclopropane derivative and a photocatalytic synthesis method thereof, so as to solve the technical problems of numerous reaction steps, harsh reaction conditions, low yield and poor functional group tolerance in the traditional synthesis method of cyclopropane derivative.
[0006] To achieve the above objectives, the present invention employs the following technical solution: This invention discloses a photocatalytic synthesis method for cyclopropane derivatives, comprising: adding an N-methyl-p-toluenesulfonamide compound, an alkenyl diazo compound, and a base to a solvent, subjecting the reaction to photocatalysis, and then separating and purifying to obtain cyclopropane derivatives. The specific structural formula of the cyclopropane derivatives is as follows: ; Wherein, R1 is selected from hydrogen, alkyl, alkynyl, tert-butyl, halogen or naphthalene; R2 is selected from alkyl, tert-butyl, halogen, alkynyl or phenyl; R3 is selected from alkyl, phenyl, halogen, alkoxy or heterocyclic.
[0007] Preferably, the general structural formula of N-methyl-p-toluenesulfonamide compounds is as follows: ; Wherein, R1 is selected from hydrogen, alkyl, alkynyl, tert-butyl, halogen or naphthalene; R2 is selected from alkyl, tert-butyl, halogen, alkynyl or phenyl.
[0008] Preferably, N-methyl-p-toluenesulfonamide compounds include N-methyl-p-chlorobenzenesulfonamide, N-methyl-p-nitrilebenzenesulfonamide, N-methyl-p-bromobenzenesulfonamide, N,3-dimethylbenzenesulfonamide, N-methylbenzenesulfonamide, N-methyl-p-fluorobenzenesulfonamide, N-methyl-p-tert-butylbenzenesulfonamide, N-methyl-p-iodobenzenesulfonamide, N,1-dimethylbenzenesulfonamide, N-methyl-p-biphenylsulfonamide, N-methyl-o-bromobenzenesulfonamide, 3-cyano-N-methylbenzenesulfonamide, 2,4-trifluoromethyl-N-methylbenzenesulfonamide, 4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide, 4-methyl-N-[(4-tolyl)sulfonyl]benzenesulfonamide, 4-methyl-N-(4-tolyl)sulfonyl]benzenesulfonamide, etc. Any one of the following: (-methoxy)benzenesulfonamide, 4-methyl-N-(but-3-en-1-yl)benzenesulfonamide, 4-methyl-N-[(4-bromophenyl)sulfonyl]benzenesulfonamide, 4-methyl-N-[(4-methoxyphenyl)sulfonyl]benzenesulfonamide, 4-methyl-N-[(4-tert-butylphenyl)sulfonyl]benzenesulfonamide, 4-methyl-N-[(4-chlorophenyl)sulfonyl]benzenesulfonamide, 4-methyl-N-[(4-ethylphenyl)sulfonyl]benzenesulfonamide, 4-methyl-N-[(4-phenyl)sulfonyl]benzenesulfonamide, 4-methyl-N-[(4-biphenyl)sulfonyl]benzenesulfonamide, and 4-methyl-N-[(4-benzyl)sulfonyl]benzenesulfonamide.
[0009] Preferably, the general structural formula of alkenyl diazo compounds is as follows: ; R3 is selected from alkyl, phenyl, halogen, alkoxy, or heterocyclic compounds.
[0010] Preferably, the alkenyl diazo compounds include any one of ethyl 2-diazobut-3-enoate, methyl 2-diazobut-3-enoate, tert-butyl 2-diazobut-3-enoate, isopropyl 2-diazobut-3-enoate, allyl 2-diazobut-3-enoate, butyl 3-en-2-yl-2-diazobut-3-enoate, ethyl (E)-2-diazopent-3-enoate, (2R,5S)-2-isopropyl-5-methylcyclohexyl-2-diazobut-3-enoate, and (1R,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptane-2-yl-2-diazobut-3-enoate.
[0011] Preferably, the molar ratio of N-methyl-p-toluenesulfonamide compounds to alkenyl diazo compounds is 1.0:3.0.
[0012] Preferably, the base is Cs2CO3, and the molar ratio of Cs2CO3 to N-methyl-p-toluenesulfonamide is 0.2:1.0; the solvent is acetonitrile; and the amount of solvent used is 1 mL of acetonitrile per 0.1 mmol of N-methyl-p-toluenesulfonamide.
[0013] Preferably, the photocatalytic reaction conditions are: stirring for 12-16 h at room temperature under 20 W blue LED irradiation.
[0014] Preferably, the separation and purification conditions are as follows: first, deionized water is added to quench the reaction, then ethyl acetate is used for extraction 2-4 times, the organic phase is collected, then anhydrous sodium sulfate is added, filtered, the solvent is removed under reduced pressure, and then rapid column chromatography is performed to obtain cyclopropane derivatives.
[0015] The present invention also discloses a cyclopropane derivative, which is prepared by the above-mentioned photocatalytic synthesis method of cyclopropane derivatives.
[0016] Compared with the prior art, the present invention has the following beneficial effects: This invention discloses a photocatalytic synthesis method for cyclopropane derivatives. Using N-methyl-p-toluenesulfonamides and alkenyl diazo compounds as raw materials, the cyclopropane derivatives are obtained after photocatalytic reaction in the presence of a base and solvent, followed by separation and purification. The sulfonamide compound is used as a nitrogen radical precursor to achieve cyclopropanation with the alkenyl diazo compound via photocatalysis. Photocatalysis promotes the in-situ generation of a nitrogen radical cationic intermediate from the sulfonamide at room temperature, which then undergoes highly regioselective and stereoselective cyclization addition with the alkenyl diazo compound. This method avoids the harsh conditions such as high temperature and high pressure required by the traditional Perkin synthesis route. Examples demonstrate that this method achieves an atom utilization rate of up to 84%, with a yield of 84% in Example 1. Furthermore, it has a wide substrate applicability, and the products are easily separated by simple extraction and column chromatography. This provides an efficient, mild, and environmentally friendly industrial prospect for the application of cyclopropane derivatives in materials and pharmaceutical fields.
[0017] This invention discloses a cyclopropane derivative exhibiting unique regioselectivity and stereoselectivity, and the method demonstrates high atom economy, aligning with the principles of green chemistry. This product eliminates the need for cumbersome multi-step traditional synthesis, directly yielding high-purity target molecules through a single photocatalytic step, with readily available raw materials. Specific embodiments and NMR and mass spectrometry data validate the correctness of the product structure. The cyclopropane skeleton is widely found in various alkaloids and drug molecules; therefore, this product possesses significant potential application value in the development of antibacterial and antiviral drugs and functional materials. Attached Figure Description
[0018] Figure 1a The product prepared in Example 1 1 H NMR spectrum; Figure 1b The product prepared in Example 1 13 C NMR spectrum; Figure 2a The product prepared in Example 2 1 H NMR spectrum; Figure 2b The product prepared in Example 2 13 C NMR spectrum; Figure 3a The product prepared in Example 3 1 H NMR spectrum; Figure 3b The product prepared in Example 3 13 C NMR spectrum; Figure 4a The product prepared in Example 4 1 H NMR spectrum; Figure 4b The product prepared in Example 4 13 C NMR spectrum; Figure 5a The product prepared in Example 5 1 H NMR spectrum; Figure 5b The product prepared in Example 5 13 C NMR spectrum; Figure 6a The product prepared in Example 6 1 H NMR spectrum; Figure 6b The product prepared in Example 6 13 C NMR spectrum; Figure 7a The product prepared in Example 7 1 H NMR spectrum; Figure 7b The product prepared in Example 7 13 C NMR spectrum; Figure 8a The product prepared in Example 8 1 H NMR spectrum; Figure 8b The product prepared in Example 8 13 C NMR spectrum; Figure 9a The product prepared in Example 91 H NMR spectrum; Figure 9b The product prepared in Example 9 13 C NMR spectrum; Figure 10a The product prepared in Example 10 1 H NMR spectrum; Figure 10b The product prepared in Example 10 13 C NMR spectrum; Figure 11a The product prepared in Example 11 1 H NMR spectrum; Figure 11b The product prepared in Example 11 13 C NMR spectrum; Figure 12a The product prepared in Example 12 1 H NMR spectrum; Figure 12b The product prepared in Example 12 13 C NMR spectrum; Figure 13a The product prepared in Example 13 1 H NMR spectrum; Figure 13b The product prepared in Example 13 13 C NMR spectrum; Figure 14a The product prepared in Example 14 1 H NMR spectrum; Figure 14b The product prepared in Example 14 13 C NMR spectrum; Detailed Implementation The technical solution of the present invention will be clearly and completely described below. Obviously, the described embodiments are only some embodiments of the present invention, not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.
[0019] Unless otherwise specified, all embodiments and preferred embodiments mentioned herein can be combined to form new technical solutions.
[0020] Unless otherwise specified, all the technical features and preferred features mentioned herein can be combined to form new technical solutions.
[0021] In this invention, unless otherwise specified, percentage (%) or parts refer to weight percentage or parts relative to the composition.
[0022] Unless otherwise specified, the components or preferred components involved in this invention can be combined with each other to form new technical solutions.
[0023] In this invention, unless otherwise specified, the numerical range "a~b" represents a shortened representation of any combination of real numbers between a and b, where a and b are both real numbers. For example, the numerical range "6~22" indicates that all real numbers between "6~22" have been listed in this document, and "6~22" is simply a shortened representation of these numerical combinations.
[0024] The "scope" disclosed in this invention can be in the form of a lower limit and an upper limit, and can be one or more lower limits and one or more upper limits, respectively.
[0025] In this invention, the term "and / or" as used herein refers to any combination of one or more of the associated listed items, as well as all possible combinations, and includes such combinations.
[0026] In this invention, unless otherwise stated, the various reactions or operation steps may be performed sequentially or in a particular order. Preferably, the reaction methods described herein are performed sequentially.
[0027] Unless otherwise stated, the technical and scientific terms used herein have the same meanings as those familiar to those skilled in the art. Furthermore, any methods or materials similar to or equivalent to those described herein may also be used in this invention.
[0028] The purpose of this invention is to provide a novel photocatalytic synthesis method for cyclopropane derivatives, thereby solving the technical problems of traditional cyclopropane derivative synthesis methods, such as numerous reaction steps, harsh reaction conditions, low yield, and poor functional group tolerance.
[0029] This invention proposes a photocatalytic synthesis method for cyclopropane derivatives, comprising: adding an N-methyl-p-toluenesulfonamide compound, an alkenyl diazo compound, and a base to a solvent, subjecting the reaction to photocatalysis, and then separating and purifying to obtain cyclopropane derivatives with the following structural formula: ; Wherein, R1 is selected from hydrogen, alkyl, alkynyl, tert-butyl, halogen or naphthalene; R2 is selected from alkyl, tert-butyl, halogen, alkynyl or phenyl; R3 is selected from alkyl, phenyl, halogen, alkoxy or heterocyclic.
[0030] In this invention, alkenyl diazo compounds act as radical acceptors, exhibiting excellent selectivity in photocatalytic reactions. Simultaneously, sulfonamides provide nitrogen radical donors, readily forming radical cationic intermediates under photocatalytic conditions, which can then undergo cycloaddition reactions with unsaturated bonds. The cyclopropane derivatives of this application meet atom economy requirements, and the starting material cyclopropane... N The atom utilization rate of methyl-p-toluenesulfonamides and alkenyl diazo compounds reached 84%, achieving the synthesis of cyclopropane while meeting atom economy requirements. Compared to traditional methods for synthesizing cyclopropane derivatives, this approach is simpler and more efficient in yielding the target product. N The atom utilization rate of methyl-p-toluenesulfonamides and alkenyl diazo compounds reaches 84%, demonstrating atom economy. The raw materials are inexpensive and readily available, resulting in low reaction costs and environmental friendliness. The reaction has good applicability to the raw materials, which are widely available. Under optimized reaction conditions, the target products are easy to separate, showing potential application value in the fields of materials and medicine.
[0031] Specifically, the photocatalytic synthesis method for cyclopropane derivatives includes the following steps: N-methyl-p-toluenesulfonamide compounds and alkenyl diazo compounds are added to acetonitrile solvent, followed by the addition of Cs₂CO₃. The air is replaced with argon and the mixture is sealed. Then, the mixture is placed at room temperature under 20W blue LED irradiation and stirred for 12-16 hours to carry out the photocatalytic reaction. After the reaction is complete, deionized water is added to quench the reaction. The mixture is extracted 2-4 times with ethyl acetate, and the organic phase is collected. The phase is dried over anhydrous sodium sulfate to remove moisture. After filtration, the solvent is removed under reduced pressure, and the mixture is subjected to rapid column chromatography to obtain the cyclopropane derivatives. The molar ratio of N-methyl-p-toluenesulfonamide compounds to alkenyl diazo compounds is 1.0:3.0. The molar ratio of Cs₂CO₃ to N-methyl-p-toluenesulfonamide compounds is 0.2:1.0. The volume ratio of acetonitrile to the molar ratio of N-methyl-p-toluenesulfonamide compounds is 1 mL:0.1 mmol.
[0032] Specifically, the reaction formulas for N-methyl-p-toluenesulfonamide compounds and alkenyl diazo compounds are as follows: ; Wherein, R1 is selected from hydrogen, alkyl, alkynyl, tert-butyl, halogen or naphthalene; R2 is selected from alkyl, tert-butyl, halogen, alkynyl or phenyl; R3 is selected from alkyl, phenyl, halogen, alkoxy or heterocyclic.
[0033] This invention discloses a photocatalytic synthesis method for cyclopropane derivatives. The method involves reacting N-methyl-p-toluenesulfonamides and alkenyl diazo compounds under a photocatalytic system to synthesize cyclopropane derivatives. This reaction proceeds rapidly at room temperature. The alkenyl diazo compounds act as radical acceptors, exhibiting good selectivity in the photocatalytic reaction. Simultaneously, the sulfonamide provides nitrogen radical donors, readily forming radical cationic intermediates under photocatalytic conditions, which can then undergo cyclization addition reactions with unsaturated bonds. This method offers high reaction efficiency and is of significant importance for the one-step synthesis of cyclopropanes and their derivatives.
[0034] The photocatalytic synthesis method for cyclopropane derivatives presented in this application is carried out at room temperature, with mild reaction conditions, broad functional group tolerance, and high reaction efficiency. It is of great significance for the one-step synthesis of cyclopropane derivatives, achieving a product yield of up to 84%. Compared to traditional synthetic methods, the photocatalytic synthesis method for cyclopropane derivatives presented in this application exhibits novel and highly efficient site selectivity, uses inexpensive and readily available raw materials, has low reaction costs, and is environmentally friendly. The reaction has good applicability to a wide range of raw material sources, and under optimized reaction conditions, the target product is easily separated, showing potential application value in the materials and pharmaceutical fields.
[0035] To ensure that N-methyl-p-toluenesulfonamide compounds exhibit better selectivity as free radical acceptors in photocatalysis, preferably, N The general structural formulas of methyl-p-toluenesulfonamide compounds are as follows: ; Wherein, R1 is selected from hydrogen, alkyl, alkynyl, tert-butyl, halogen or naphthalene; R2 is selected from alkyl, tert-butyl, halogen, alkynyl or phenyl.
[0036] To further improve the selectivity of N-methyl-p-toluenesulfonamide compounds, preferably, the N-methyl-p-toluenesulfonamide compounds are selected from N-methyl-p-chlorobenzenesulfonamide, N-methyl-p-nitrilebenzenesulfonamide, N-methyl-p-bromobenzenesulfonamide, N,3-dimethylbenzenesulfonamide, N-methylbenzenesulfonamide, N-methyl-p-fluorobenzenesulfonamide, N-methyl-p-tert-butylbenzenesulfonamide, N-methyl-p-iodobenzenesulfonamide, N,1-dimethylbenzenesulfonamide, N-methyl-p-biphenylsulfonamide, N-methyl-o-bromobenzenesulfonamide, 3-cyano-N-methylbenzenesulfonamide, 2,4-trifluoromethyl-N-methylbenzenesulfonamide, 4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide, and 4-methyl-N-[(4-tolyl)sulfonyl] One of the following: benzenesulfonamide, 4-methyl-N-(4-methoxy)benzenesulfonamide, 4-methyl-N-(but-3-en-1-yl)benzenesulfonamide, 4-methyl-N-[(4-bromophenyl)sulfonyl]benzenesulfonamide, 4-methyl-N-[(4-methoxyphenyl)sulfonyl]benzenesulfonamide, 4-methyl-N-[(4-tert-butylphenyl)sulfonyl]benzenesulfonamide, 4-methyl-N-[(4-chlorophenyl)sulfonyl]benzenesulfonamide, 4-methyl-N-[(4-ethylphenyl)sulfonyl]benzenesulfonamide, 4-methyl-N-[(4-phenyl)sulfonyl]benzenesulfonamide, 4-methyl-N-[(4-biphenyl)sulfonyl]benzenesulfonamide, and 4-methyl-N-[(4-benzyl)sulfonyl]benzenesulfonamide.
[0037] To ensure that the alkenyl diazo compounds can fully complete the free radical addition reaction with N-methyl-p-toluenesulfonamide compounds under photocatalytic conditions, the molar ratio of N-methyl-p-toluenesulfonamide compounds to alkenyl diazo compounds is preferably 1.0:3.0.
[0038] To ensure the photocatalytic reaction between alkenyl diazo compounds and N-methyl-p-toluenesulfonamide compounds is fully completed, preferably, the base is Cs₂CO₃, and the molar ratio of Cs₂CO₃ to N-methyl-p-toluenesulfonamide compounds is 0.2:1.0; the solvent is acetonitrile, and the volume ratio of the solvent to the molar ratio of N-methyl-p-toluenesulfonamide compounds is 1 mL:0.1 mmol.
[0039] To further promote the photocatalytic reaction, ensure the raw materials react fully, and maximize the product yield, the preferred conditions for the photocatalytic reaction are: stirring for 12-16 hours at room temperature under 20W blue LED irradiation.
[0040] To obtain cyclopropane derivatives, the preferred separation and purification conditions are as follows: after the photocatalytic reaction, deionized water is added for quenching, followed by extraction with ethyl acetate 2-4 times. The ethyl acetate is collected, dried with anhydrous sodium sulfate, filtered, and subjected to rapid column chromatography under reduced pressure to finally obtain the cyclopropane derivatives.
[0041] The present invention also discloses cyclopropane derivatives synthesized by the above-mentioned synthesis method. These cyclopropane derivatives meet the requirements of atom economy, and the atom utilization rate of the raw materials, cycloN-methyl-p-toluenesulfonamide compounds and alkenyl diazo compounds, reaches 84%. The synthesis of cyclopropane was completed under the requirement of atom economy.
[0042] To make the objectives, technical solutions, and advantages of the embodiments of the present invention clearer, the technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some, not all, of the embodiments of the present invention. The components of the embodiments of the present invention described and shown in the accompanying drawings can generally be arranged and designed in various different configurations. Therefore, the following detailed description of the embodiments of the present invention provided in the accompanying drawings is not intended to limit the scope of the claimed invention, but merely to illustrate selected embodiments of the invention. All other embodiments obtained by those skilled in the art based on the embodiments of the present invention without inventive effort are within the scope of protection of the present invention.
[0043] In the following examples and comparative examples, the raw materials are all common commercially available products that can be purchased directly or can be prepared using conventional techniques in the field.
[0044] Examples of the photocatalytic synthesis method for cyclopropane derivatives of the present invention.
[0045] Example 1 A method for preparing a cyclopropane derivative (1S, 2S)-2-((N,4-dimethylphenyl)sulfonamido)cyclopropane-1-carboxylate, comprising: N-methyl-p-toluenesulfonamide (0.1 mmol) and Cs₂CO₃ (0.2 mmol) were weighed and added to a 10 mL transmissive clamp tube. After adding acetonitrile (1.0 mL) as the reaction solvent, ethyl alkenyl diazoacetate (0.3 mmol) was added using a pipette. The air was replaced with nitrogen and the tube was sealed. The tube was then stirred under 20 W blue light for 16 h. After the reaction was complete, an aqueous solution was added to quench the reaction. The tube was extracted three times with ethyl acetate, and the organic phase was collected, dried over anhydrous sodium sulfate, filtered, and the solvent was removed under reduced pressure. The solution was then subjected to rapid column chromatography (V petroleum ether: V ethyl acetate = 6:1) to obtain 25.2 mg of a colorless oily substance, with a yield of 84% [Product separation yield (%) = (actual molar mass of pure product obtained / theoretical maximum molar mass of product) × 100%]. The structural formula of the obtained product is as follows: .
[0046] Figure 1a The image shows the 1H NMR spectrum of the product prepared in Example 1. Figure 1b The 13C NMR spectrum of the product prepared in Example 1 is shown in the figure; the NMR characterization of the product is also shown. cis isomer: 1 H NMR (400 MHz, Chloroform- d ) δ 7.62(d, J = 8.1 Hz, 2H), 7.27 (d, J = 8.0 Hz, 2H), 4.06 (q, J = 7.2 Hz, 2H), 2.66 (s,3H), 2.36 (s, 3H), 2.20 (dt, J = 7.3, 3.7 Hz, 1H), 1.94 (dd, J = 6.2, 2.8 Hz, 1H), 1.48 (dt, J = 9.7, 5.0 Hz, 1H), 1.30 (q, J = 5.9 Hz, 1H), 1.19 (t, J = 7.1 Hz, 3H). 13 HRMS (ESI) m / z: [M+H] + Calculated. For C 14 H 20 NO4S + : 298.1108, Found 298.1101. Example 2 The preparation method of an cyclopropane derivative, Ethyl(1S,2S)-2-(N-methylphenylsulfonamido)cyclopropane-1-carboxylate, is basically the same as that in Example 1, except that N-methylbenzenesulfonamide is selected as the N-methyl-p-toluenesulfonamide compound, yielding 13.6 mg of a colorless oily substance with a yield of 41%. The structural formula of the obtained product is as follows: .
[0047] Figure 2aThe 1H NMR spectrum of the product prepared in Example 2; Figure 2b The 13C NMR spectrum of the product prepared in Example 2 is shown in the figure. The product's NMR characterization is as follows: cis isomer: 1H NMR (400 MHz, Chloroform-d) δ 7.82 (d, J = 7.3 Hz, 2H), 7.66 – 7.61 (m, 1H), 7.56 (t, J = 7.5 Hz, 2H), 4.14 (q, J = 7.1 Hz, 2H), 2.76 (s, 3H), 2.34 – 2.28 (m, 1H), 2.09 – 2.00 (m, 1H), 1.57 (dt, J = 9.7, 5.0 Hz, 1H), 1.42 – 1.36 (m, 1H), 1.27 (t, J = 7.1 Hz, 3H). 13CNMR (101 MHz, Chloroform-d) δ 172.22, 144.04, 129.82, 128.06, 61.03, 40.11,37.48, 22.38, 21.60, 17.07, 14.27. HRMS (ESI) m / z: [M+H]+ Calcd. ForC13H18NO4S+: 284.0951, Found 284.0959. Example 3 The preparation method of a cyclopropane derivative, Ethyl(1S,2S)-2-((4-(tert-butyl)-N-methylphenyl)sulfonamido)cyclopropane-1-carboxylate, is basically the same as that in Example 1, except that N-methyl-p-toluenesulfonamide is selected as N-methyl-p-tert-butylbenzenesulfonamide, yielding 23.1 mg of a colorless oily product with a yield of 68%. The structural formula of the obtained product is as follows: .
[0048] Figure 3a The product prepared in Example 3 1 H NMR spectrum; Figure 3b The product prepared in Example 3 13C NMR spectrum; as shown in the figure, the product's NMR characterization: cis isomer: 1H NMR (400 MHz, CDCl3) δ 7.76 – 7.70 (m, 2H), 7.61 – 7.51 (m, 2H), 4.14 (qd, J = 7.2, 3.0 Hz, 2H), 2.75 (s, 3H), 2.32 (m, J = 7.4, 4.7, 2.7 Hz, 3H), 2.03 (m, J = 9.1, 6.0, 2.7 Hz, 1H), 1.58 (dd, J = 9.7, 5.0 Hz, 1H), 1.42 – 1.37 (m, 2H), 1.35 (s, 9H), 1.27 (t, J = 7.2 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 172.34, 156.95, 132.30, 127.93,126.19, 61.06, 40.13, 37.56, 35.26, 31.13, 22.39, 17.25, 14.27. HRMS (ESI) m / z: [M+H]+ Calcd. For C17H26NO4S+: 340.4575, Found 340.4583. Example 4 The preparation method of a cyclopropane derivative, Ethyl(1S,2S)-2-((4-fluoro-N-methylphenyl)sulfonamido)cyclopropane-1-carboxylate, is basically the same as that in Example 1, except that N-methyl-p-toluenesulfonamide is selected as N-methyl-p-fluorobenzenesulfonamide, yielding 15.95 mg of a colorless oily substance with a yield of 53%. The structural formula of the obtained product is as follows: .
[0049] Figure 4a The image shows the 1H NMR spectrum of the product prepared in Example 4. Figure 4bThe 13C NMR spectrum of the product prepared in Example 4 is shown in the figure. Product NMR characterization: cis isomer: 1H NMR (400 MHz, CDCl3) δ 7.82 – 7.72 (m, 2H), 7.59 – 7.50 (m, 2H), 4.23 – 4.08 (m, 2H), 2.75 (s, 3H), 2.30 (m, J = 7.4, 4.7, 2.7 Hz, 1H), 2.03 (m, J = 9.2, 6.0, 2.7 Hz, 1H), 1.56 (dt, J = 9.8, 5.1 Hz, 1H), 1.39 (dt, J = 7.3, 5.7 Hz, 1H), 1.27 (t, J = 7.2 Hz). Hz,3H). 13C NMR (101 MHz, CDCl3) δ 172.04, 139.91, 133.92, 129.51 (d, J = 17.8 Hz), 61.17, 39.94, 37.48, 22.43, 17.05, 14.29. HRMS (ESI) m / z [M + H]+ For C13H17FNO4S+:302.0857, Found 302.0851. Example 5 The preparation method of a cyclopropane derivative, Ethyl(1R,2S)-2-((4-chloro-N-methylphenyl)sulfonamido)cyclopropane-1-carboxylate, is basically the same as that in Example 1, except that N-methyl-p-toluenesulfonamide is selected as N-methyl-p-chlorobenzenesulfonamide, yielding 25.9 mg of a colorless oily substance with a yield of 82%. The structural formula of the obtained product is as follows: .
[0050] Figure 5a The product prepared in Example 5 1 H NMR spectrum; Figure 5b The product prepared in Example 5 13C10 NMR spectrum; as shown in the figure, the product's NMR characterization: cis isomer: 1H NMR (600 MHz, CDCl3) δ 7.84 – 7.68 (m, 2H), 7.64 – 7.44 (m, 2H), 4.14 (q, J = 7.1 Hz, 2H), 2.76 (s, 3H), 2.30 (m, J = 7.4, 4.7, 2.7 Hz, 1H), 2.03 (m, J = 9.1, 6.0, 2.7 Hz, 1H), 1.54 (d, J = 5.0 Hz, 1H), 1.39 (dt, J = 7.4, 5.7 Hz, 1H), 1.28 (t, J = 7.1 Hz, 3H). 13CNMR (101 MHz, CDCl3) δ 172.05, 139.89, 133.80, 129.50 (d, J = 18.4 Hz), 61.18, 39.93, 37.50, 22.39, 17.09, 14.29. HRMS (ESI) m / z [M + H]+ Calcd. ForC13H17ClNO4S+: 318.0561, Found 318.0571. Example 6 The preparation method of a cyclopropane derivative ethyl(1S,2S)-2-((4-iodo-N-methylphenyl)sulfonamido)cyclopropane-1-carboxylate is basically the same as that in Example 1, except that N-methyl-p-toluenesulfonamide is selected as N-methyl-p-iodobenzenesulfonamide, yielding 24.06 mg of a colorless oily substance with a yield of 60%. The structural formula of the obtained product is as follows: .
[0051] Figure 6a The product prepared in Example 6 1 H NMR spectrum; Figure 6b The product prepared in Example 6 1313C NMR spectrum; as shown in the figure, the product's NMR characterization is as follows: 1H NMR (400 MHz, CDCl3) δ 8.01 – 7.81 (m, 2H), 7.59 – 7.44 (m, 2H), 4.13 (qd, J = 7.1, 1.0 Hz, 2H), 2.74 (s, 3H), 2.28 (m, J = 7.4, 4.7, 2.7 Hz, 1H), 2.02 (m, J = 9.1, 6.0, 2.8 Hz, 1H), 1.54 (dt, J = 9.8, 5.1 Hz, 1H), 1.38 (dt, J = 7.4, 5.7 Hz, 1H), 1.26 (t, J = 7.2 Hz, 3H). (151 MHz, CDCl3) δ 171.97, 138.52, 135.12, 129.31, 100.84, 61.13,39.91, 37.43, 22.40, 16.98, 14.28. HRMS (ESI) m / z [M + H]+ Calcd. ForC13H17INO4S+: 409.9917, Found 409.9926. Example 7 The preparation method of a cyclopropane derivative ethyl(1S,2S)-2-((4-cyano-N-methylphenyl)sulfonamido)cyclopropane-1-carboxylate is basically the same as that in Example 1, except that N-methyl-p-toluenesulfonamide is selected as N-methyl-p-nitrilebenzenesulfonamide, yielding 15.1 mg of a colorless oil with a yield of 49%. The structural formula of the obtained product is as follows: .
[0052] Figure 7a The product prepared in Example 7 1 H NMR spectrum; Figure 7b The product prepared in Example 7 13C NMR spectrum; as shown in the figure, the product's NMR characterization: cis isomer: 1H NMR (600 MHz, CDCl3) δ 7.97 – 7.91 (m, 2H), 7.87 (d, J = 8.3 Hz, 2H), 4.15 (qd, J = 6.7, 6.2, 1.8 Hz, 2H), 2.79 (d, J = 1.6 Hz, 3H), 2.33 (m, J = 7.4, 4.6, 2.7 Hz, 1H), 2.05 (m, J = 9.1, 6.0, 2.6 Hz, 1H), 1.61 – 1.57 (m, 1H), 1.41 (dt, J = 7.4, 5.8 Hz, 1H), 1.28 (t, J = 7.2 Hz, 3H). 13C NMR (151 MHz, CDCl3) δ 171.89, 139.73, 133.12,128.64, 117.28, 117.05, 61.34, 39.78, 37.54, 22.47, 17.12, 14.33. HRMS (ESI)m / z [M + H]+ Calcd.For C13H17CN2O4S+: 309.0904, Found 309.0914. Example 8 The preparation method of a cyclopropane derivative, Ethyl(1S,2S)-2-((N-methyl-4-nitrophenyl)sulfonamido)cyclopropane-1-carboxylate, is basically the same as that in Example 1, except that N-methyl-p-toluenesulfonamide is selected as N-methyl-p-nitrobenzenesulfonamide, yielding 19.68 mg of a colorless oily substance with a yield of 60%. The structural formula of the obtained product is as follows: .
[0053] Figure 8a The product prepared in Example 8 1 H NMR spectrum; Figure 8b The product prepared in Example 8 13C NMR spectrum; as shown in the figure, the product's NMR characterization: 1H NMR (400 MHz, CDCl3) δ 8.42 (d, J = 8.5 Hz, 2H), 8.01 (d, J = 8.5 Hz, 2H), 4.15 (q, J = 7.1 Hz, 2H), 2.81 (s, 3H), 2.34 (m, J = 7.5, 4.6, 2.7 Hz, 1H), 2.06 (m, J = 9.2, 6.1, 2.7 Hz, 1H), 1.60 –1.55 (m, 1H), 1.42 (q, J = 6.2 Hz, 1H), 1.28 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ For C13H17N2O6S+:329.0802, Found 329.0812. Example 9 The preparation method of a cyclopropane derivative, Ethyl(1S,2S)-2-((4-cyano-N-methylphenyl)sulfonamido)cyclopropane-1-carboxylate, is basically the same as that in Example 1, except that N-methyl-p-toluenesulfonamide is selected as N-methyl-p-biphenylsulfonamide, yielding 12.9 mg of a colorless oily product with a yield of 36%. The structural formula of the obtained product is as follows: .
[0054] Figure 9a The product prepared in Example 9 1 H NMR spectrum; Figure 9b The product prepared in Example 9 13C NMR spectrum; as shown in the figure, the product's NMR characterization: cis isomer: 1H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 8.4 Hz, 2H), 7.76 (d, J = 8.2 Hz, 2H), 7.61 (d, J = 7.2 Hz, 2H), 7.49 (dd, J = 8.4, 6.6 Hz, 2H), 7.44 (d, J = 7.2 Hz, 1H), 4.15 (q, J = 7.1 Hz, 2H), 2.80 (s, 3H), 2.37 (m, J = 7.4, 4.6, 2.7 Hz, 1H), 2.06 (m, J = 8.8, 5.8, 2.5 Hz, 1H), 1.60 (dt, J = 9.9, 5.1 Hz, 1H), 1.42 (dt, J = 7.3, 5.6 Hz, 1H), 1.28 (t,J = 7.2 Hz, 3H).13C NMR (101 MHz, CDCl3) δ 172.19, 146.16, 139.29, For C19H22NO4S+: 360.1264, Found360.1254. Example 10 The preparation method of an cyclopropane derivative, Ethyl(1S,2S)-2-((N,3-dimethylphenyl)sulfonamido)cyclopropane-1-carboxylate, is basically the same as that in Example 1, except that N-methyl-p-toluenesulfonamide is selected as N-3-dimethylbenzenesulfonamide, yielding 13.01 mg of a colorless oily substance with a yield of 44%. The structural formula of the obtained product is as follows: .
[0055] Figure 10a The product prepared in Example 10 1 H NMR spectrum; Figure 10b The product prepared in Example 10 13CNMR spectrum; as shown in the figure, the product's NMR characterization: cis isomer: 1H NMR (400 MHz, CDCl3) δ 7.60 (q, J = 3.0 Hz, 2H), 7.51 – 7.38 (m, 2H), 4.13 (qd, J = 7.1, 2.3 Hz, 2H), 2.74 (s, 3H), 2.43 (s, 3H), 2.30 (m, J = 7.3, 4.7, 2.7 Hz, 1H), 2.02 (m, J = 9.1, 6.0, 2.7 Hz, 1H), 1.54 (dt, J = 9.7, 5.1 Hz, 1H), 1.37 (dt, J = 7.3, 5.7 Hz, 1H), 1.26 (t, J = 7.2 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 172.17, 139.37,135.03, 133.94, 129.00, 128.21, 125.10, 61.01, 40.00, 37.47, 22.28, 21.40,17.09, 14.20. HRMS (ESI) m / z [M + H]+ calcd for Calcd. For C14H20NO4S+:298.1108, Found 298.1115. Example 11 The preparation method of a cyclopropane derivative (1S,2S)-2-((N,4-dimethylphenyl)sulfonamido)cyclopropane-1-carboxylate is basically the same as that in Example 1, except that methyl 2-diazobut-3-enoate is selected as the alkenyl diazo compound, yielding 16.6 mg of a colorless oil with a yield of 59%. The structural formula of the obtained product is as follows: .
[0056] Figure 11a The product prepared in Example 11 1 H NMR spectrum; Figure 11b The product prepared in Example 11 13CNMR spectrum; as shown in the figure, the product's NMR characterization: cis isomer: 1H NMR (400 MHz, CDCl3) δ 7.69 (d, J = 8.0 Hz, 2H), 7.35 (d, J = 7.9 Hz, 2H), 3.69 (s, 3H), 2.73 (s, 3H), 2.44 (s, 3H), 2.29 (m, J = 7.5, 4.5, 2.7 Hz, 1H), 2.04 (m, J = 9.0, 5.9, 2.7 Hz, 1H), 1.57 (dt, J = 9.8, 5.1 Hz, 1H), 1.43 – 1.33 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 172.65, 144.08, 132.40, 129.84, 128.04, 52.14, 40.17, 37.48, 22.22,21.61, 17.17. HRMS (ESI) m / z [M + H]+ Calcd. 284.0951, Found284.0942. Example 12 The preparation method of a cyclopropane derivative (1S,2S)-2-((N,4-dimethylphenyl)sulfonamido)cyclopropane-1-carboxylate is basically the same as that in Example 1, except that: the alkenyl diazo compound selected isopropyl 2-diazobut-3-enoic acid, yielding 22.08 mg of a colorless oily substance with a yield of 71%. The structural formula of the obtained product is as follows: .
[0057] Figure 12a The product prepared in Example 12 1 H NMR spectrum; Figure 12b The product prepared in Example 12 13CNMR spectrum; as shown in the figure, the product's NMR characterization: cis isomer: 1H NMR (400 MHz, CDCl3) δ 7.69 (d, J = 7.9 Hz, 2H), 7.34 (d, J = 7.9 Hz, 2H), 4.98 (p, J = 6.3 Hz, 1H), 2.74 (s, 3H), 2.44 (s, 3H), 2.25 (dq, J = 7.4, 3.5, 3.0 Hz, 1H), 2.01 (m, J = 9.1, 6.0, 2.7 Hz, 1H), 1.56 – 1.46 (m, 1H), 1.35 (q, J = 6.2 Hz, 1H), 1.24 (t, J = 6.4 Hz, 6H). 13C NMR (101 MHz, CDCl3) δ 171.69, 144.02, 132.46, 129.81,128.05, 68.44, 40.06, 37.48, 22.64, 21.85 (d, J = 8.7 Hz), 21.60, 16.87. HRMS(ESI) m / z [M + H]+ Calcd. For C15H22NO4S+: 312.1264, Found 312.1275. Example 13 The preparation method of a cyclopropane derivative (1S,2S)-2-((N,4-dimethylphenyl)sulfonamido)cyclopropane-1-carboxylate is basically the same as that in Example 1, except that: tert-butyl 2-diazobut-3-enoic acid is selected as the alkenyl diazo compound, yielding 19.17 mg of a colorless oil with a yield of 57%. The structural formula of the obtained product is as follows: .
[0058] Figure 13a The product prepared in Example 13 1 H NMR spectrum; Figure 13b The product prepared in Example 13 13CNMR spectra; as shown in the figure, the product's NMR characterization: cis isomer: 1H NMR (400 MHz, CDCl3) δ 7.88 –7.63 (m,2H), 7.34 (d, J = 7.8 Hz, 2H), 2.74 (d, J = 1.6 Hz, 3H), 2.44 (s,3H), 2.20 (tt, J = 6.1, 2.7 Hz, 1H), 1.96 (s, 1H), 1.45 (d, J = 1.6 Hz,9H), 1.33 – 1.23 (m,2H). 13C NMR (101 MHz, CDCl3) δ 171.41, 143.97, 132.47, 129.78, 128.06, 81.15, 53.47, 39.90, 37.49, 28.15, 23.30, 21.60, 16.67. HRMS(ESI) m / z [M + H]+ Calcd. For C16H24NO4S+: 326.1421, Found 326.1431. Example 14 The preparation method of a cyclopropane derivative (1S,2S)-2-((N,4-dimethylphenyl)sulfonamido)cyclopropane-1-carboxylate is basically the same as that in Example 1, except that: the alkenyl diazo compound selected is allyl 2-diazobut-3-enoate, yielding 15.5 mg of a colorless oily substance in 50% yield. The structural formula of the obtained product is as follows: .
[0059] Figure 14a The product prepared in Example 14 1 H NMR spectrum; Figure 14b The product prepared in Example 14 13CNMR spectrum; as shown in the figure, the product's NMR characterization: cis isomer: 1H NMR (400 MHz, CDCl3) δ 7.69 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 7.9 Hz, 2H), 5.91 (ddt, J = 16.3, 11.0, 5.7 Hz, 1H), 5.42 – 5.19 (m, 2H), 4.59 (d, J = 5.6 Hz, 2H), 2.74 (s, 3H), 2.44 (s, 3H), 2.30 (td, J = 4.9, 2.5 Hz, 1H), 2.07 (m, J = 9.1, 6.0, 2.7 Hz, 1H), 1.57 (dt, J = 9.7, 5.0 Hz, 1H), 1.39 (dt, J = 7.3, 5.6 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 171.87, 144.07, 132.41, 131.98, 129.84, 128.05, 118.50, 65.63,40.23, 37.47, 22.33, 21.60, 17.16. HRMS (ESI) m / z [M + H]+ Calcd. ForC15H20NO4S+: 310.1108, Found 310.1118. In summary, the present invention provides a cyclopropane derivative and its photocatalytic synthesis method, using N-methyl-p-toluenesulfonamide and alkenyl diazo compounds as raw materials. In the presence of an alkali in acetonitrile solvent, the sulfonamide is irradiated with a 20 W blue LED at room temperature for 12-16 hours, causing the sulfonamide to generate a nitrogen radical intermediate in situ under photocatalysis. This intermediate then undergoes a highly regioselective and stereoselective cyclization addition reaction with the alkenyl diazo compound. The target product can then be obtained by simple extraction, drying, and column chromatography separation. The reaction is carried out under mild conditions at room temperature, without the need for high temperature and high pressure, making it simple and safe to operate with significantly reduced energy consumption. It boasts high atom economy, aligning with green chemistry principles; Example 1 shows a yield of up to 84%, and exhibits excellent substrate versatility, compatible with various substituents such as hydrogen, alkyl, alkynyl, tert-butyl, halogen, naphthalene, phenyl, alkoxy, and heterocyclic groups. It also demonstrates good tolerance to halogen, cyano, and nitro functional groups. This photocatalytic system achieves efficient coupling of N-methyl-p-toluenesulfonamides with alkenyl diazo compounds, constructing a cyclopropane skeleton in one step. This overcomes the problems of cumbersome steps, demanding conditions, and low yields associated with traditional synthetic routes. It has broad application prospects and significant industrial application value in materials science, medicinal chemistry, and natural product synthesis.
[0060] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, and not to limit them; although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art should understand that modifications can still be made to the technical solutions described in the foregoing embodiments, or equivalent substitutions can be made to some or all of the technical features; and these modifications or substitutions do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.
Claims
1. A photocatalytic synthesis method for cyclopropane derivatives, characterized in that, include: Will N Methyl-p-toluenesulfonamides, alkenyl diazo compounds, and bases are added to a solvent, and after photocatalytic reaction, they are separated and purified to obtain cyclopropane derivatives. The structural formulas of the cyclopropane derivatives are as follows: ; Wherein, R1 is selected from hydrogen, alkyl, alkynyl, tert-butyl, halogen or naphthalene; R2 is selected from alkyl, tert-butyl, halogen, alkynyl or phenyl; R3 is selected from alkyl, phenyl, halogen, alkoxy or heterocyclic.
2. The photocatalytic synthesis method for cyclopropane derivatives according to claim 1, characterized in that, The N The general structural formulas of methyl-p-toluenesulfonamide compounds are as follows: ; Wherein, R1 is selected from hydrogen, alkyl, alkynyl, tert-butyl, halogen or naphthalene; R2 is selected from alkyl, tert-butyl, halogen, alkynyl or phenyl.
3. The photocatalytic synthesis method for cyclopropane derivatives according to claim 1, characterized in that, The N-methyl-p-toluenesulfonamide compounds include N-methyl-p-chlorobenzenesulfonamide, N-methyl-p-nitrilebenzenesulfonamide, N-methyl-p-bromobenzenesulfonamide, N,3-dimethylbenzenesulfonamide, N-methylbenzenesulfonamide, N-methyl-p-fluorobenzenesulfonamide, N-methyl-p-tert-butylbenzenesulfonamide, N-methyl-p-iodobenzenesulfonamide, N,1-dimethylbenzenesulfonamide, N-methyl-p-biphenylsulfonamide, N-methyl-o-bromobenzenesulfonamide, 3-cyano-N-methylbenzenesulfonamide, 2,4-trifluoromethyl-N-methylbenzenesulfonamide, 4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide, 4-methyl-N-[(4-tolyl)sulfonyl]benzenesulfonamide, 4-methyl-N-(4- The methoxybenzenesulfonamide, 4-methyl-N-(but-3-en-1-yl)benzenesulfonamide, 4-methyl-N-[(4-bromophenyl)sulfonyl]benzenesulfonamide, 4-methyl-N-[(4-methoxyphenyl)sulfonyl]benzenesulfonamide, 4-methyl-N-[(4-tert-butylphenyl)sulfonyl]benzenesulfonamide, 4-methyl-N-[(4-chlorophenyl)sulfonyl]benzenesulfonamide, 4-methyl-N-[(4-ethylphenyl)sulfonyl]benzenesulfonamide, 4-methyl-N-[(4-phenyl)sulfonyl]benzenesulfonamide, 4-methyl-N-[(4-biphenyl)sulfonyl]benzenesulfonamide, and 4-methyl-N-[(4-benzyl)sulfonyl]benzenesulfonamide.
4. The photocatalytic synthesis method for cyclopropane derivatives according to claim 1, characterized in that, The general structural formula of the alkenyl diazo compounds is as follows: ; R3 is selected from alkyl, phenyl, halogen, alkoxy, or heterocyclic compounds.
5. The photocatalytic synthesis method for cyclopropane derivatives according to claim 1, characterized in that, The alkenyl diazo compounds include any one of ethyl 2-diazobut-3-enoate, methyl 2-diazobut-3-enoate, tert-butyl 2-diazobut-3-enoate, isopropyl 2-diazobut-3-enoate, allyl 2-diazobut-3-enoate, butyl 3-en-2-yl-2-diazobut-3-enoate, ethyl (E)-2-diazopent-3-enoate, (2R,5S)-2-isopropyl-5-methylcyclohexyl-2-diazobut-3-enoate, and (1R,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptane-2-yl-2-diazobut-3-enoate.
6. The photocatalytic synthesis method for cyclopropane derivatives according to claim 1, characterized in that, The molar ratio of the N-methyl-p-toluenesulfonamide compound to the alkenyl diazo compound is 1.0:3.
0.
7. The photocatalytic synthesis method for cyclopropane derivatives according to claim 1, characterized in that, The base is Cs2CO3, and the molar ratio of Cs2CO3 to N-methyl-p-toluenesulfonamide is 0.2:1.0; the solvent is acetonitrile; and the amount of solvent used is 1 mL of acetonitrile per 0.1 mmol of N-methyl-p-toluenesulfonamide.
8. The photocatalytic synthesis method for cyclopropane derivatives according to claim 1, characterized in that, The conditions for the photocatalytic reaction are: stirring for 12-16 h at room temperature under 20 W blue LED irradiation.
9. The photocatalytic synthesis method for cyclopropane derivatives according to claim 1, characterized in that, The separation and purification conditions are as follows: first, deionized water is added to quench the reaction, then ethyl acetate is used for extraction 2-4 times, the organic phase is collected, then anhydrous sodium sulfate is added, filtered, the solvent is removed under reduced pressure, and then rapid column chromatography is performed to obtain cyclopropane derivatives.
10. A cyclopropane derivative, characterized in that, It is prepared by the photocatalytic synthesis method of cyclopropane derivatives according to any one of claims 1-9.
